nach oben

The European Journal of Health Economics

Erschienen in:

01.12.2011 | Editorial

Budget impact analysis in economic evaluation: a proposal for a clearer definition

verfasst von: Livio Garattini, Katelijne van de Vooren

Erschienen in: The European Journal of Health Economics | Ausgabe 6/2011

Einloggen, um Zugang zu erhalten

Excerpt

Budget impact analysis (BIA) is a relatively recent method for economic evaluation (EE) in the field of health care. It assesses the financial consequences of the introduction of a new technology in a specific setting in the short-to-medium term [1]. BIA is supposed to be complementary to more established types of EEs, providing additional information for decisions on the reimbursement of new technology [1]. …

Trueman, P., Drummond, M., Hutton, J.: Developing guidance for budget impact analysis. Pharmacoeconomics 19, 609–621 (2001)PubMedCrossRef

Mauskopf, J.A., Sullivan, S.D., Annemans, L., et al.: Principles of good practice for budget impact analysis: report of the ISPOR task force on good research practices-budget impact analysis. Value Health 10, 336–347 (2007)PubMedCrossRef

Marshall, D.A., Douglas, P.R., Drummond, M.F., et al.: Guidelines for conducting pharmaceutical budget impact analyses for submission to public drug plans in Canada. Pharmacoeconomics 26, 477–495 (2008)PubMedCrossRef

Orlewska, E., Gulácsi, L.: Budget-impact analyses, a critical review of published studies. Pharmacoeconomics 27, 807–827 (2009)PubMedCrossRef

Weinstein, M., Siegel, J., Gold, M., Kamlet, M., et al.: Recommendations of the panel on cost-effectiveness in health and medicine. JAMA 276, 1253–1258 (1996)PubMedCrossRef

Drummond, M., O’Brien, B., Stoddart, G., Torrance, G.: Methods for the economic evaluation of health care programmes, 2nd edn. Oxford Medical Publications, Oxford (1997)

Orlewska, E., Mierzejewski, P.: Proposal of polish guidelines for conducting financial analysis and their comparison to existing guidance on budget impact in other countries. Value Health 7, 1–10 (2004)PubMedCrossRef

Nuijten, M., Mittendorf, T., Persson, U.: Practical issues in handling data input and uncertainty in a budget impact analysis. Eur. J. Health Econ. 12, 231–241 (2011)PubMedCrossRef

Garattini, L., Grilli, R., Scopelliti, D., Mantovani, L.: A proposal for Italian guidelines in pharmacoeconomics. Pharmacoeconomics 7, 1–6 (1995)PubMedCrossRef

10.

Drummond, M., Dubois, D., Garattini, L., Horisberger, B., et al.: Current trends in the use of pharmacoeconomics and outcomes research in Europe. Value Health 2, 323–332 (1999)

11.

Hutter, F., Antoñanzas, F.: Economic evaluations in the EURONHEED: a comparative analysis. Pharmacoeconomics 27, 561–570 (2009)

Titel: Budget impact analysis in economic evaluation: a proposal for a clearer definition
verfasst von: Livio Garattini
Katelijne van de Vooren
Publikationsdatum: 01.12.2011
Verlag: Springer-Verlag
Erschienen in: The European Journal of Health Economics / Ausgabe 6/2011
Print ISSN: 1618-7598
Elektronische ISSN: 1618-7601
DOI: https://doi.org/10.1007/s10198-011-0348-5

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2011

Direct costs of Alzheimer’s disease in Germany

The impact of repeated cost containment policies on pharmaceutical expenditure: experience in Spain

How removing prescription drugs from reimbursement lists increases the pharmaceutical expenditures for alternatives

Cost efficiency of university hospitals in the Nordic countries: a cross-country analysis

Do you believe in magic? Improving the quality of pharmacy services through restricting entry and aspirational contracts, the Irish experience

Exploring the relationship between costs and quality: Does the joint evaluation of costs and quality alter the ranking of Danish hospital departments?